58
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Apolipoprotein A-IV polymorphism in Saami and Finns: frequency and effect on serum lipid levels

, , , , , , , , & show all
Pages 218-223 | Received 11 Jun 1997, Accepted 05 Jan 1998, Published online: 08 Jul 2009

References

  • Green P H, Glickman R M, Riley J W, Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911–9
  • Utermann G, Beisiegel U. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 1979; 99: 333–43
  • Steinmetz A, Utermann G. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 1985; 260: 2258–64
  • Stein O, Stein Y, Lefevre M, Roheim P S. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biocbim Biophys Acta 1986; 878: 7–13
  • Barter P J, Rajaram O V, Chang L B, et al. Isolation of a high-density- lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator. Biochem J 1988; 254: 179–84
  • Tcnkanen H, Ehnholm C. Molecular basis for apo A-IV polymorphisms. Ann Med 1992; 24: 369–74
  • Lukka M, Metso J, Ehnholm C. Apolipoprotein A-IV polymorphism in the Finnish population: gene frequencies and description of a rare allele. Hum Hered 1988; 38: 359–62
  • Tenkanen H, Koskinen P, Metso J, et al. A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127. Biocbim Biophys Acta 1992; 1138: 27–33
  • Tenkanen H, Lukka M, Jauhiainen M, et al. The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360. Arterioscler Thromb 1991; 11: 851–6
  • Utermann G, Feussner G, Franceschini G, Haas J, Steinmetz A. Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. J Biol Chem 1982; 257: 501–7
  • Menzel H J, Dieplinger H, Sandholzer C, Karadi I, Utermann G, Csaszar A. Apolipoprotein A-IV polymorphism in the Hungarian population: gene frequencies, effect on lipid levels, and sequence of two new variants. Hum Mutat 1995; 5: 58–65
  • Menzel H J, Sigurdsson G, Boerwinkle E, Schrangl-Wiil S, Dieplinger H X, Utermann G. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 1990; 84: 344–6
  • Menzel H J, Boerwinkle E, Schrangl-Will S, Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 1988; 79: 368–72
  • Ehnholm C, Tenkanen H, de Knijff P, et al. Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. European Atherosclerosis Research Study. Atherosclerosis 1994; 107: 229–38
  • de Knijff P, Johansen L G, Rosseneu M, et al. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb 1992; 12: 1371–9
  • de Knijff P, Rosseneu M, Beisiegel U, de Keersgieter W, Frants R RX, Havekes L M. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 1988; 29: 1621–7
  • Visvikis S, Steinmetz J, Boerwinkle E, Gueguen R, Galteau M M, Siest G. Frequency and effects of the apolipoprotein A-IV polymorphism. Clin Genet 1990; 37: 435–41
  • Kamboh M I, Friedlaender J S, Arm Y I, Ferrell R E. A common deletion polymorphism in the apolipoprotein A4 gene and its significance in lipid metabolism. Arterioscler Thromb 1994; 14: 656–62
  • Kamboh M L, Iyengar S, Aston C E, Hamman R F, Ferrell R E. Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado. Hum Biol 1992; 64: 605–16
  • Malle E, Pfeiffer K P, Dugi K, et al. Polymorphisms of apolipoproteins A-IV and E in a Turkish population living in Germany. Hum Genet 1996; 98: 285–90
  • Hanis C L, Douglas T C, Hewett-Emmett D. Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 1991; 86: 323–5
  • Berg K, Borresen A L. Serum-high-density-lipoprotein and atherosclerotic heart-disease. Lancet 1976; 1: 499–501
  • Bierman E L, Oram J F. The interaction of high-density lipoproteins with extrahepatic cells. Am Heart J 1987; 113: 549–50
  • Sajantila A, Lahermo P, Anttinen T, et al. Genes and languages in Europe. An analysis of mitochondrial lineages. Genome Res 1995; 5: 42–52
  • Sajantila A, Salem A H, Savolainen P, Bauer K, Gierig C, Paabo S. Paternal and maternal DNA lineages reveal a bottleneck in the founding of the Finnish population. Proc Natl Acad Sci USA 1996; 93: 12035–9
  • Nayha S, Hassi J. Life Style, Work and Health of Finnish Reindeer Herders. Publications of the Social Insurance Institution, ML, HelsinkiFinland 1993; 127
  • Luoma P V, Näyhä S, Sikkilä K, Hassi J. High serum alpha-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. J Intern Med 1995; 237: 49–54
  • Lehtinen S, Lehtimäki T, Luoma P, Näyhä S, Ehnholm C, Nikkari T. Differences in allele distribution of apolipoprotein E between Saami and Finns. Eur J Lab Med 1996; 4: 39–44
  • Menzel H J, Utermann G. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis 1986; 7: 492–5
  • Lehtimaki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487–95
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4
  • Siedel J, Hagele E O, Ziegenhorn J, Wahlefeld A W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075–80
  • Finley P R, Schifman R B, Williams R J, Lichti D A. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem 1978; 24: 931–3
  • Wahlefeld A W. Triglycerides. Determination after enzymatic hydrolysis. Methods of Enzymatic Analysis, H U Bergmeyer. Academic Press, New York 1974; 1831–5
  • Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
  • Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-l and B in serum. Scand J Clin Lab Invest 1987; 47: 739–44
  • Menzel H J, Kovary P M, Assmann G. Apolipoprotein A-IV polymorphism in man. Hum Genet 1982; 62: 349–52
  • Lohse P, Brewer H B, Jr. Genetic polymorphism of apolipoprotein A-IV. Curr Opin Lipidol 1991; 2: 90–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.